Ageno, W et al. “Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.” Journal of thrombosis and haemostasis : JTH vol. 11,1 (2013): 177-9. doi:10.1111/jth.
Akpan, Imo J, and Adam Cuker. “Laboratory assessment of the direct oral anticoagulants: who can benefit?.” Kardiologia polska vol. 79,6 (2021): 622-630. doi:10.33963/KP.a2021.0021
Chen,Ashley et al.Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.Journal of the American Heart Association vol. 9,13 (2020): e017559. doi:10.1161/JAHA.120.017559
Douxfils J,Adcock DM, Bates SM, Favaloro EJ, Gouin-Thibault I, Guillermo C, Kawai Y, Lindhoff-Last E, Kitchen S, Gosselin RC. 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost. 2021 Aug;121(8):1008-1020. doi: 10.1055/a-1450-8178. Epub 2021 Mar 19. PMID: 33742436.
Gorr, Haeshik S et al. “Reversal of direct oral anticoagulants: Highlights from the Anticoagulation Forum guideline.” Cleveland Clinic journal of medicine vol. 88,2 98-103. 1 Feb. 2021, doi:10.3949/ccjm.88a.19133
Gosselin, RC, Adcock, DM & Douxfils, J 2019, 'An update on laboratory assessment for direct oral anticoagulants (DOACs)', International Journal of Laboratory Hematology, vol. 41, no. S1, pp. 33-39. https://doi.org/10.1111/ijlh.12992.
Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis a
Surgery (EACTS). Eur Heart J. 2021; 42(5): 373–498, doi: 10.1093/eurheartj/ehaa612, indexed in Pubmed: 32860505.
Levy,Jerrold H et al.;Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis; Research and practice in thrombosis and haemostasis vol. 4,4 562-568. 2 Mar. 2020, doi:10.1002/rth2.12320
Smock KJ: Update on Anticoagulants Monitoring Practice, (2017) ARUP Laboratories,www.arup.org, accessed May 18, 2022.
Stacy,Zachary A et al. Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism. Cardiology and therapy vol. 5,1 (2016): 1-18. doi:10.1007/s40119-016-0058-2
Tomaselli,Gordon F et al. “2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.” Journal of the American College of Cardiology vol. 76,5 (2020): 594-622. doi:10.1016/j.jacc.2020.04.053
Tripodi, Armando et al. “Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.” Blood transfusion = Trasfusione del sangue vol. 16,5 (2018): 462-470. doi:10.2450/2017.0124-17
Turgeon, M. Linne & Ringsrud's Clinical Laboratory Science, ed.8, Chapter 12 Hemostasis and Blood Coagulation, St. Louis,Elsevier, 2020, 358-379.
Turgeon M: Clinical Hematology, ed.6, Chapter 27 Principles of Hemostasis and Thrombosis and Chapter28 Disorders of Hemostasis and Thrombosis, Philadelphia, Lippincott, 2018, 526-582.
Vasilios Perifanis, Nikolaos Neokleous,Dimitrios A. Tsakiris, Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs), Thrombosis Update,Volume 5,2021,100084,ISSN 2666-5727, https://doi.org/10.1016/j.tru.2021.100084.
